Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

218 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The transition from normal lung anatomy to minimal and established fibrosis in idiopathic pulmonary fibrosis (IPF).
Xu F, Tanabe N, Vasilescu DM, McDonough JE, Coxson HO, Ikezoe K, Kinose D, Ng KW, Verleden SE, Wuyts WA, Vanaudenaerde BM, Verschakelen J, Cooper JD, Lenburg ME, Morshead KB, Abbas AR, Arron JR, Spira A, Hackett TL, Colby TV, Ryerson CJ, Ng RT, Hogg JC. Xu F, et al. Among authors: verleden se. EBioMedicine. 2021 Apr;66:103325. doi: 10.1016/j.ebiom.2021.103325. Epub 2021 Apr 13. EBioMedicine. 2021. PMID: 33862585 Free PMC article.
Macrolide therapy targets a specific phenotype in respiratory medicine: from clinical experience to basic science and back.
Vanaudenaerde BM, Vos R, Meyts I, De Vleeschauwer SI, Verleden SE, Widyastuti-Willems A, Wuyts WA, Van Raemdonck DE, Hoet PH, Dupont LJ, Nemery B, Verleden GM. Vanaudenaerde BM, et al. Among authors: verleden se, verleden gm. Inflamm Allergy Drug Targets. 2008 Dec;7(4):279-87. doi: 10.2174/187152808786848414. Inflamm Allergy Drug Targets. 2008. PMID: 19075792 Review.
Obliterative bronchiolitis following lung transplantation: from old to new concepts?
Verleden GM, Vos R, De Vleeschauwer SI, Willems-Widyastuti A, Verleden SE, Dupont LJ, Van Raemdonck DE, Vanaudenaerde BM. Verleden GM, et al. Among authors: verleden se. Transpl Int. 2009 Aug;22(8):771-9. doi: 10.1111/j.1432-2277.2009.00872.x. Epub 2009 Mar 26. Transpl Int. 2009. PMID: 19490538 Free article. Review.
Long-term azithromycin therapy for bronchiolitis obliterans syndrome: divide and conquer?
Vos R, Vanaudenaerde BM, Ottevaere A, Verleden SE, De Vleeschauwer SI, Willems-Widyastuti A, Wauters S, Van Raemdonck DE, Nawrot TS, Dupont LJ, Verleden GM. Vos R, et al. Among authors: verleden se, verleden gm. J Heart Lung Transplant. 2010 Dec;29(12):1358-68. doi: 10.1016/j.healun.2010.05.023. Epub 2010 Jul 8. J Heart Lung Transplant. 2010. PMID: 20619683
Phenotyping BOS could improve understanding of mechanisms involved.
Verleden SE, Verleden GM, Vanaudenaerde BM. Verleden SE, et al. Among authors: verleden gm. J Heart Lung Transplant. 2011 Jan;30(1):112; author reply 113. doi: 10.1016/j.healun.2010.07.014. Epub 2010 Sep 19. J Heart Lung Transplant. 2011. PMID: 20855218 No abstract available.
Azithromycin reduces pulmonary fibrosis in a bleomycin mouse model.
Wuyts WA, Willems S, Vos R, Vanaudenaerde BM, De Vleeschauwer SI, Rinaldi M, Vanhooren HM, Geudens N, Verleden SE, Demedts MG, Thomeer M, Verbeken EK, Verleden GM. Wuyts WA, et al. Among authors: verleden se, verleden gm. Exp Lung Res. 2010 Dec;36(10):602-14. doi: 10.3109/01902148.2010.492895. Epub 2010 Sep 27. Exp Lung Res. 2010. PMID: 20874225 Free article.
Innate and adaptive interleukin-17-producing lymphocytes in chronic inflammatory lung disorders.
Vanaudenaerde BM, Verleden SE, Vos R, De Vleeschauwer SI, Willems-Widyastuti A, Geenens R, Van Raemdonck DE, Dupont LJ, Verbeken EK, Meyts I. Vanaudenaerde BM, et al. Among authors: verleden se. Am J Respir Crit Care Med. 2011 Apr 15;183(8):977-86. doi: 10.1164/rccm.201007-1196PP. Epub 2010 Nov 19. Am J Respir Crit Care Med. 2011. PMID: 21097694 Review.
218 results